Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-21 Purchase | 2023-04-24 09:03 am | Genprex Inc. | GNPX | Varner John Rodney Chairman, President and CEO | 19,000 | $1.055 | $20,045 | 1,180,535 (Indirect Direct) | View |
| 2023-04-21 Purchase | 2023-04-24 09:00 am | Genprex Inc. | GNPX | VACZY CATHERINE M EVP GC Chief Strategy Officer | 20,000 | $1.0739 | $21,478 | 265,000 (Direct) | View |
| 2021-04-05 Purchase | 2021-04-07 4:41 pm | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 15,000 | $4.15 | $62,250 | 35,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-05 Option Award | 2024-12-06 5:55 pm | N/A N/A | Genprex Inc. | GNPX | Moreno Toscano Jose Antonio Director | 4,750 | $0 | 7,845 (Direct) | View |
| 2024-12-05 Option Award | 2024-12-06 5:53 pm | N/A N/A | Genprex Inc. | GNPX | Wilson William R Jr. Director | 4,750 | $0 | 7,845 (Direct) | View |
| 2024-12-05 Option Award | 2024-12-06 5:51 pm | N/A N/A | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 4,750 | $0 | 8,720 (Direct) | View |
| 2024-12-05 Option Award | 2024-12-06 5:50 pm | N/A N/A | Genprex Inc. | GNPX | Confer Ryan M. President, CEO and CFO | 29,375 | $0 | 39,138 (Direct) | View |
| 2024-12-05 Option Award | 2024-12-06 5:48 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 18,250 | $0 | 23,056 (Direct) | View |
| 2024-02-18 Tax Withholding | 2024-02-21 4:34 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 1,319 | $4.4 | 4,806 (Direct) | View |
| 2024-02-18 Tax Withholding | 2024-02-21 4:32 pm | N/A N/A | Genprex Inc. | GNPX | Varner John Rodney Chairman, President and CEO | 2,642 | $4.4 | 26,872 (Direct) | View |
| 2024-02-18 Tax Withholding | 2024-02-21 4:28 pm | N/A N/A | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 1,126 | $4.4 | 9,763 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 6:09 pm | N/A N/A | Genprex Inc. | GNPX | Moreno Toscano Jose Antonio Director | 123,795 | $0 | 123,795 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 6:07 pm | N/A N/A | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 123,795 | $0 | 158,795 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 6:02 pm | N/A N/A | Genprex Inc. | GNPX | Wilson William R Jr. Director | 123,795 | $0 | 123,795 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:36 pm | N/A N/A | Genprex Inc. | GNPX | VACZY CATHERINE M EVP GC Chief Strategy Officer | 245,000 | $0 | 245,000 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:35 pm | N/A N/A | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 245,000 | $0 | 245,000 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:28 pm | N/A N/A | Genprex Inc. | GNPX | Kumar Hermant Chief Mfgr & Tech Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:25 pm | N/A N/A | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 245,000 | $0 | 435,499 (Direct) | View |
| 2023-02-18 Option Award | 2023-02-22 6:21 pm | N/A N/A | Genprex Inc. | GNPX | Varner John Rodney President & CEO | 625,000 | $0 | 1,161,535 (Direct) | View |
| 2022-07-28 Exercise | 2022-08-01 5:30 pm | N/A N/A | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 116,973 | $0.015 | 190,499 (Direct) | View |
| 2022-07-28 Exercise | 2022-08-01 5:30 pm | 2013-08-01 2022-07-31 | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 116,973 | $0 | 190,499 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:01 pm | 2023-06-23 2032-06-23 | Genprex Inc. | GNPX | Moreno Toscano Jose Antonio Director | 83,368 | $0 | 83,368 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:48 pm | 2023-06-23 2032-06-23 | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 83,368 | $0 | 83,368 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:47 pm | 2023-06-23 2032-06-23 | Genprex Inc. | GNPX | Wilson William R Jr. Director | 83,368 | $0 | 83,368 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:45 pm | 2023-06-23 2032-06-23 | Genprex Inc. | GNPX | Kumar Hermant Chief Mfgr & Tech Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-06-14 Ownership | 2022-02-14 4:48 pm | N/A N/A | Genprex Inc. | GNPX | Varner John Rodney President & CEO | 1,614,152 | $0 | 546,535 (Indirect) | View |
Ownership | 2022-02-14 4:48 pm | N/A N/A | Genprex Inc. | GNPX | Varner John Rodney President & CEO | 0 | $0 | 546,535 (Indirect) | View |
| 2022-02-04 Option Award | 2022-02-08 4:43 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | VACZY CATHERINE M EVP GC Chief Strategy Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:38 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 341,750 | $0 | 341,750 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:35 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | Varner John Rodney President & CEO | 1,062,250 | $0 | 1,062,250 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:32 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 98,750 | $0 | 98,750 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:29 pm | 2023-02-04 2032-02-04 | Genprex Inc. | GNPX | Kumar Hermant Chief Mfgr & Tech Officer | 54,312 | $0 | 54,312 (Direct) | View |
| 2021-09-27 Option Award | 2021-09-28 4:28 pm | 2022-09-27 2031-09-27 | Genprex Inc. | GNPX | Kumar Hermant Chief Mfgr & Tech Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-09-28 4:26 pm | 2022-09-27 2031-09-27 | Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer | 550,000 | $0 | 550,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 7:08 pm | 2022-06-24 2031-06-24 | Genprex Inc. | GNPX | Wilson William R Jr. Director | 32,376 | $0 | 32,376 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 7:05 pm | 2022-06-24 2031-06-24 | Genprex Inc. | GNPX | Moreno Toscano Jose Antonio Director | 32,376 | $0 | 32,376 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 7:03 pm | 2022-06-24 2031-06-24 | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 32,376 | $0 | 32,376 (Direct) | View |
Ownership(A) | 2021-04-07 4:37 pm | N/A N/A | Genprex Inc. | GNPX | LONGNECKER BRENT M Director | 0 | $0 | 31,775 (Indirect) | View |
| 2021-03-19 Option Award | 2021-03-23 4:48 pm | 2024-03-19 2031-03-19 | Genprex Inc. | GNPX | Confer Ryan M. Chief Financial Officer | 235,000 | $0 | 235,000 (Direct) | View |
| 2021-03-19 Option Award | 2021-03-23 4:48 pm | 2024-03-19 2031-03-19 | Genprex Inc. | GNPX | VACZY CATHERINE M EVP GC Chief Strategy Officer | 200,000 | $0 | 200,000 (Direct) | View |